Tag: Osimertinib

Medical entrepreneurs applaud customs duty exemption on cancer medication

Posted on By admin

Medical entrepreneurs in Hyderabad have welcomed the exemption of customs duties on three cancer medications as announced in the Union Budget 2024-25. “Cancer treatment is notoriously expensive, often placing an overwhelming financial burden on patients and their families. By removing these duties, the cost of these medications will be reduced, making them accessible. This measure…

Read More “Medical entrepreneurs applaud customs duty exemption on cancer medication” »

Business

Budget provides customs duty exemptions for three cancer treatment drugs

Posted on By admin

Union government has continued its emphasis on tackling non-communicable diseases, and allocating funds for research in the healthcare sector, with Finance Minister Nirmala Sitharaman on July 23 announcing customs duty exemptions on three cancer treatment drugs — Trastuzumab Deruxtecan, Osimertinib, and Durvalumab. | Photo Credit: Getty Images/iStock The Union government has continued its emphasis on…

Read More “Budget provides customs duty exemptions for three cancer treatment drugs” »

Business